Jonathan Hernández-Mancera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jonathan Hernández-Mancera has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Adriano Basso Dias
Joint Department of Medical Imaging (JDMI), University of Toronto, Toronto, Canada
1 shared publication - Alessandra Borgheresi
Department of Clinical, Special and Dental Sciences, University Politecnica delle Marche, Ancona, Italy
1 shared publication Alessandro Crestani
Urology Unit, University Hospital S. Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy
1 shared publicationAndrea Ponsiglione
Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy
1 shared publication- Anwar Roshanali Padhani
Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, England
1 shared publication - Arnaldo Stanzione
Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy
1 shared publication
Latest Publications
- 5 November 2026
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
The need for clarity in the nomenclature of kidney cysts
- 5 November 2026
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
The need for clarity in the nomenclature of kidney cysts
- 1 November 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 8 (6)
Risk-adapted MRI Protocols for the Detection of Clinically Significant Prostate Cancer
Diagnostic performance and clinical utility of prostate MRI protocols differed by prebiopsy risk category, with multiparametric MRI showing higher sensitivity in intermediate-risk patients and similar performance across protocols in low- and high-risk patients.
- 1 November 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 8 (6)
Risk-adapted MRI Protocols for the Detection of Clinically Significant Prostate Cancer
Diagnostic performance and clinical utility of prostate MRI protocols differed by prebiopsy risk category, with multiparametric MRI showing higher sensitivity in intermediate-risk patients and similar performance across protocols in low- and high-risk patients.
- 4 June 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (12) , 6110-6124
Image-guided percutaneous ablation techniques for the treatment of renal cell carcinoma: a primer for radiologists
Percutaneous renal tumor ablation (RTA) has become an established treatment option for selected patients with small renal masses, particularly cT1a tumors in patients with relevant comorbidity, hereditary renal tumor syndromes, impaired renal function, or a solitary kidney. In this review, we summarize current indications for RTA, the main ablation technologies, image-guidance strategies, preprocedural planning, adjunctive techniques, intraprocedural considerations, complications, and post-ablation follow-up. We also review current evidence comparing RTA with partial nephrectomy, with particular attention to oncologic outcomes, renal function preservation, and morbidity. Although guideline recommendations remain relatively conservative, accumulating evidence supports percutaneous ablation as an important nephron-sparing treatment option in appropriately selected patients. This review aims to provide radiologists with a practical overview of contemporary renal tumor ablation and its role in the multidisciplinary management of renal cell carcinoma.
- 4 June 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (12) , 6110-6124
Image-guided percutaneous ablation techniques for the treatment of renal cell carcinoma: a primer for radiologists
Percutaneous renal tumor ablation (RTA) has become an established treatment option for selected patients with small renal masses, particularly cT1a tumors in patients with relevant comorbidity, hereditary renal tumor syndromes, impaired renal function, or a solitary kidney. In this review, we summarize current indications for RTA, the main ablation technologies, image-guidance strategies, preprocedural planning, adjunctive techniques, intraprocedural considerations, complications, and post-ablation follow-up. We also review current evidence comparing RTA with partial nephrectomy, with particular attention to oncologic outcomes, renal function preservation, and morbidity. Although guideline recommendations remain relatively conservative, accumulating evidence supports percutaneous ablation as an important nephron-sparing treatment option in appropriately selected patients. This review aims to provide radiologists with a practical overview of contemporary renal tumor ablation and its role in the multidisciplinary management of renal cell carcinoma.